Involvement of blockade of leukotriene B(4) action in anti-pruritic effects of emedastine in mice

Eur J Pharmacol. 2000 Oct 6;406(1):149-52. doi: 10.1016/s0014-2999(00)00637-3.

Abstract

The anti-pruritic activity of emedastine difumarate was studied in mice. Emedastine (0.03-0.3 mg/kg) inhibited scratching induced by intradermal injection of histamine (100 nmol/site). Scratching induced by substance P (100 nmol/site) and leukotriene B(4) (0.03 nmol/site), but not by serotonin (100 nmol/site), was also suppressed by emedastine (0.03-0.3 mg/kg). Intradermal injection of substance P increased the cutaneous concentration of leukotriene B(4), which was not affected by emedastine. These results suggest that the inhibition by emedastine of substance P-induced itch-associated response is mediated by the blockade of leukotriene B(4) action. Anti-leukotriene B(4) action, as well as the anti-histamine action, may contribute to the anti-pruritic effects of emedastine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Allergic Agents / pharmacology*
  • Benzimidazoles / pharmacology*
  • Dose-Response Relationship, Drug
  • Histamine / administration & dosage
  • Injections, Intradermal
  • Leukotriene B4 / administration & dosage*
  • Leukotriene B4 / metabolism
  • Male
  • Mice
  • Mice, Inbred ICR
  • Pruritus / chemically induced
  • Pruritus / prevention & control*
  • Serotonin / administration & dosage
  • Substance P / administration & dosage

Substances

  • Anti-Allergic Agents
  • Benzimidazoles
  • Leukotriene B4
  • Serotonin
  • Substance P
  • Histamine
  • emedastine